| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |